![Logo of OpenAlex.org Project OpenAlex Citations Logo](https://www.oahelper.org/wp-content/plugins/oahelper-citations/img/logo-openalex.jpg)
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Innovations in Antibody-Drug Conjugate (ADC) in the Treatment of Lymphoma
Ali Al Sbihi, Maryam Alasfour, Georgios Pongas
Cancers (2024) Vol. 16, Iss. 4, pp. 827-827
Open Access | Times Cited: 7
Ali Al Sbihi, Maryam Alasfour, Georgios Pongas
Cancers (2024) Vol. 16, Iss. 4, pp. 827-827
Open Access | Times Cited: 7
Showing 7 citing articles:
The potential of antibody-drug conjugates for effective therapy in diffuse large B-cell lymphoma
Gulrayz Ahmed, Mehdi Hamadani, Taha Al‐Juhaishi
Expert Opinion on Biological Therapy (2025)
Closed Access
Gulrayz Ahmed, Mehdi Hamadani, Taha Al‐Juhaishi
Expert Opinion on Biological Therapy (2025)
Closed Access
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas
Francesco D’Alò, Silvia Bellesi, Elena Maiolo, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2243-2243
Open Access | Times Cited: 3
Francesco D’Alò, Silvia Bellesi, Elena Maiolo, et al.
Cancers (2024) Vol. 16, Iss. 12, pp. 2243-2243
Open Access | Times Cited: 3
Disulfidptosis: A Novel Prognostic Criterion and Potential Treatment Strategy for Diffuse Large B-Cell Lymphoma (DLBCL)
Yu Wang, Yoshiyuki Tsukamoto, Mitsuo Hori, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7156-7156
Open Access | Times Cited: 2
Yu Wang, Yoshiyuki Tsukamoto, Mitsuo Hori, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7156-7156
Open Access | Times Cited: 2
Antibody–Drug Conjugates—Evolution and Perspectives
Adriana Aurelia Chiş, Carmen Maximiliana Dobrea, Anca Maria Arseniu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6969-6969
Open Access | Times Cited: 1
Adriana Aurelia Chiş, Carmen Maximiliana Dobrea, Anca Maria Arseniu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 6969-6969
Open Access | Times Cited: 1
Tumor Biology Hides Novel Therapeutic Approaches to Diffuse Large B-Cell Lymphoma: A Narrative Review
Romana Masnikosa, Zorica Cvetković, David Pirić
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11384-11384
Open Access
Romana Masnikosa, Zorica Cvetković, David Pirić
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11384-11384
Open Access
Determination of the decapping efficiency of THIOMAB™ antibodies with the engineered cysteine in the Fc region for making antibody–drug conjugates by specific hinge fragmentation-liquid chromatography
Yun Yang, Jaymin Patel, Rong‐Sheng Yang, et al.
Analytical and Bioanalytical Chemistry (2024)
Closed Access
Yun Yang, Jaymin Patel, Rong‐Sheng Yang, et al.
Analytical and Bioanalytical Chemistry (2024)
Closed Access
Hepatopulmonary syndrome associated with long-term use of ado-trastuzumab emtansine (T-DM1) for treatment of HER2-positive metastatic breast cancer - a case report and series
Ciara C. O’Sullivan, Alexandra Higgins, Adham K. Alkurashi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access
Ciara C. O’Sullivan, Alexandra Higgins, Adham K. Alkurashi, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access